IKS014

· Iksuda Therapeutics Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IKS014, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: IKS014 in Advanced Solid Tumors That Express HER2 [Phase 1]